INJECTION SITE INFECTION

This adverse event was reported 3289 times

These drugs are most commonly taken by patients reporting INJECTION SITE INFECTION:

# Drug Count
0 INTERFERON BETA-1A 412
1 TREPROSTINIL 348
2 ETANERCEPT 188
3 BUPRENORPHINE 168
4 INTERFERON BETA-1B 148
5 TADALAFIL 146
6 AMBRISENTAN 131
7 GLATIRAMER ACETATE 115
8 ADALIMUMAB 114
9 NALTREXONE 110
See all common drugs associated with INJECTION SITE INFECTION

INJECTION SITE INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sclerosing Agent [EPC] 2 0.0044
1 CD4-directed Blocking Antibody [EPC] 2 0.0037
2 Prostacycline [EPC] 3 0.0032
3 Carboxypeptidase [EPC] 1 0.0028
4 Prostacycline Vasodilator [EPC] 350 0.0025
5 Interferon beta [EPC] 413 0.0021
6 Partial Opioid Agonist [EPC] 168 0.0018
7 Soluble Guanylate Cyclase Stimulator [EPC] 45 0.0013
8 Phosphodiesterase 5 Inhibitor [EPC] 166 0.0012
9 Endothelin Receptor Antagonist [EPC] 226 0.0011
See all drug classes enriched for association with INJECTION SITE INFECTION